Loading...
XJPX
6678
Market cap91mUSD
Dec 05, Last price  
2,058.00JPY
1D
-0.24%
1Q
0.83%
Jan 2017
4.79%
IPO
86.53%
Name

Techno Medica Co Ltd

Chart & Performance

D1W1MN
XJPX:6678 chart
P/E
14.20
P/S
1.44
EPS
144.97
Div Yield, %
3.30%
Shrs. gr., 5y
-3.99%
Rev. gr., 5y
0.19%
Revenues
9.91b
-3.68%
6,668,551,0006,730,946,0007,055,186,0007,559,455,0007,980,933,0008,151,194,0009,000,060,0009,519,640,0009,032,422,0008,457,238,0008,654,247,0009,332,420,0009,810,534,0009,040,115,0009,699,077,0009,367,586,00010,283,851,0009,905,864,000
Net income
1.00b
-25.48%
873,233,000846,212,000784,077,000933,526,0001,074,418,0001,243,745,0001,355,064,0001,486,533,0001,197,035,000458,128,0001,308,516,0001,098,100,0001,000,452,0001,153,260,0001,281,384,0001,150,733,0001,348,130,0001,004,583,000
CFO
978m
-14.45%
543,613,000124,427,000683,560,000744,796,000732,904,0001,282,503,0001,051,651,0001,729,325,0001,075,474,000695,462,0001,517,084,000704,255,0001,269,281,000825,412,0002,062,978,000887,240,0001,142,703,000977,535,000
Dividend
Mar 30, 202668 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Techno Medica Co., Ltd. engages in the research and development, manufacture, sale, import, and export of in-vitro diagnostic analyzers in Japan. The company offers test tube preparation, automatic urine aliquot, RFID specimen management, and RFID blood transfusion management, as well as blood gas, electrolyte, Erythrocyte Sedimentation Rate, nutrient, sugar and acid, and urine chemistry analyzers; electronic medical charts and pre-analytical instruments; and consumables and after sales services. Techno Medica Co., Ltd. was incorporated in 1987 and is headquartered in Yokohama, Japan.
IPO date
Sep 17, 2003
Employees
225
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT